Literature DB >> 7621448

Anti-tumour and antioxidant activity of natural curcuminoids.

A J Ruby1, G Kuttan, K D Babu, K N Rajasekharan, R Kuttan.   

Abstract

Matural curcuminoids, curcumin, I, II and III isolated from turmeric (Curcuma longa) were compared for their cytotoxic, tumour reducing and antioxidant activities. Curcumin III was found to be more active than the other two as a cytotoxic agent and in the inhibition of Ehrlich ascites tumour in mice (ILS 74.1%). These compounds were also checked for their antioxidant activity which possibly indicates their potential use as anti-promoters. The amount of curcuminoids (I, II and III) needed for 50% inhibition of lipid peroxidation was 20, 14 and 11 g/m. Concentrations needed for 50% inhibition of superoxides were 6.25, 4.25 and 1.9 micrograms/ml and those for hydroxyl radical were 2.3, 1.8 and 1.8 micrograms/ml, respectively. The ability of these compounds to suppress the superoxide production by macrophages activated with phorbol-12-myristate-13-acetate (PMA) indicated that all the three curcuminoids inhibited superoxide production and curcumin III produced maximum effect. These results indicate that curcumin III is the most active of the curcuminoids present in turmeric. Synthetic curcumin I and III had similar activity to natural curcumins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621448     DOI: 10.1016/0304-3835(95)03827-j

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  152 in total

1.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

2.  Evaluation of the Efficacy of Curcumin in the Treatment of Oral Lichen Planus: A Randomized Controlled Trial.

Authors:  Maryam Amirchaghmaghi; Atessa Pakfetrat; Zahra Delavarian; Hanieh Ghalavani; Ala Ghazi
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.

Authors:  Lei Shi; Xifeng Fei; Zhimin Wang
Journal:  Tumour Biol       Date:  2015-04-16

4.  Morin, a plant derived flavonoid, modulates the expression of peroxisome proliferator-activated receptor-γ coactivator-1α mediated by AMPK pathway in hepatic stellate cells.

Authors:  Wei Yuan; Shoaib Ahmad; Ajaz Najar
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

5.  Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS).

Authors:  Saipin Setthacheewakul; Wichan Kedjinda; Duangkhae Maneenuan; Ruedeekorn Wiwattanapatapee
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

6.  Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins.

Authors:  J Song; B Choi; E-J Jin; Y Yoon; K-H Choi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-19       Impact factor: 3.267

7.  Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.

Authors:  Li Lin; Qian Shi; Alexander K Nyarko; Kenneth F Bastow; Chin-Chung Wu; Ching-Yuan Su; Charles C-Y Shih; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2006-06-29       Impact factor: 7.446

8.  Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model.

Authors:  Ahmet Turan Isik; Turgay Celik; Gokhan Ulusoy; Onder Ongoru; Birsen Elibol; Huseyin Doruk; Ergun Bozoglu; Hakan Kayir; Mehmet Refik Mas; Serif Akman
Journal:  Age (Dordr)       Date:  2008-10-08

9.  Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.

Authors:  Liang Leng; Xiaojun Zhong; Guan Sun; Wen Qiu; Lei Shi
Journal:  Tumour Biol       Date:  2016-10-18

10.  Does Curcumin Have an Anticaries Effect? A Systematic Review of In Vitro Studies.

Authors:  Ailin Ehteshami; Farinaz Shirban; Fateme Gharibpour; Mohammad Bagherniya; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.